These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 19053243
1. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB. ACS Chem Biol; 2008 Dec 19; 3(12):765-75. PubMed ID: 19053243 [Abstract] [Full Text] [Related]
2. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M. Eur J Med Chem; 2019 Nov 15; 182():111628. PubMed ID: 31472473 [Abstract] [Full Text] [Related]
3. A small-molecule dengue virus entry inhibitor. Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG. Antimicrob Agents Chemother; 2009 May 15; 53(5):1823-31. PubMed ID: 19223625 [Abstract] [Full Text] [Related]
4. Discovery of novel dengue virus entry inhibitors via a structure-based approach. Leal ES, Aucar MG, Gebhard LG, Iglesias NG, Pascual MJ, Casal JJ, Gamarnik AV, Cavasotto CN, Bollini M. Bioorg Med Chem Lett; 2017 Aug 15; 27(16):3851-3855. PubMed ID: 28668194 [Abstract] [Full Text] [Related]
5. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR. Antiviral Res; 2009 Dec 15; 84(3):234-41. PubMed ID: 19781577 [Abstract] [Full Text] [Related]
6. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M, Singh SK. Curr Top Med Chem; 2018 Dec 15; 18(18):1585-1602. PubMed ID: 30360716 [Abstract] [Full Text] [Related]
7. A small molecule fusion inhibitor of dengue virus. Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W. Antiviral Res; 2009 Dec 15; 84(3):260-6. PubMed ID: 19800368 [Abstract] [Full Text] [Related]
8. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS, Wu KX, Chen KC, Ng MM, Chu JJ. Antivir Ther; 2011 Dec 15; 16(8):1203-18. PubMed ID: 22155902 [Abstract] [Full Text] [Related]
9. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL. ACS Infect Dis; 2018 Sep 14; 4(9):1395-1406. PubMed ID: 30027735 [Abstract] [Full Text] [Related]
10. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL. Cell Chem Biol; 2018 Aug 16; 25(8):1006-1016.e8. PubMed ID: 29937406 [Abstract] [Full Text] [Related]
11. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. Lim SV, Rahman MB, Tejo BA. BMC Bioinformatics; 2011 Aug 16; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153 [Abstract] [Full Text] [Related]
12. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Anasir MI, Ramanathan B, Poh CL. Viruses; 2020 Mar 26; 12(4):. PubMed ID: 32225021 [Abstract] [Full Text] [Related]
13. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads. Gangopadhyay A, Chakraborty HJ, Datta A. J Mol Graph Model; 2017 May 26; 73():129-142. PubMed ID: 28279821 [Abstract] [Full Text] [Related]
14. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation. Ahmed M, Kumar A, Hobman TC, Barakat K. J Mol Graph Model; 2019 Jul 26; 90():128-143. PubMed ID: 31082639 [Abstract] [Full Text] [Related]
15. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. J Mol Graph Model; 2018 Jan 26; 79():88-102. PubMed ID: 29156382 [Abstract] [Full Text] [Related]
16. Identification of novel target sites and an inhibitor of the dengue virus E protein. Yennamalli R, Subbarao N, Kampmann T, McGeary RP, Young PR, Kobe B. J Comput Aided Mol Des; 2009 Jun 26; 23(6):333-41. PubMed ID: 19241120 [Abstract] [Full Text] [Related]
17. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase. Xu HT, Colby-Germinario SP, Hassounah S, Quashie PK, Han Y, Oliveira M, Stranix BR, Wainberg MA. Antimicrob Agents Chemother; 2016 Jan 26; 60(1):600-8. PubMed ID: 26574011 [Abstract] [Full Text] [Related]
18. Identification of small molecule inhibitors targeting the Zika virus envelope protein. Pitts J, Hsia CY, Lian W, Wang J, Pfeil MP, Kwiatkowski N, Li Z, Jang J, Gray NS, Yang PL. Antiviral Res; 2019 Apr 26; 164():147-153. PubMed ID: 30771406 [Abstract] [Full Text] [Related]
19. Peptide inhibitors against dengue virus infection. Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2014 Aug 26; 84(2):148-57. PubMed ID: 24612829 [Abstract] [Full Text] [Related]
20. Novel approaches to flavivirus drug discovery. Botting C, Kuhn RJ. Expert Opin Drug Discov; 2012 May 26; 7(5):417-28. PubMed ID: 22439769 [Abstract] [Full Text] [Related] Page: [Next] [New Search]